In this cohort study, we systematically investigated the association of CAA imaging markers with downstream AD plasma biomarkers (p-tau217, GFAP, and NfL) in relation to Aβ uptake on PET in a large Asian cohort. Here, GFAP is linked to Alzheimer disease.